INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 27 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $299,000 | -33.3% | 403,000 | +33.0% | 0.01% | -7.1% |
Q1 2022 | $448,000 | +0.7% | 303,000 | 0.0% | 0.01% | -36.4% |
Q4 2021 | $445,000 | -22.7% | 303,000 | 0.0% | 0.02% | -50.0% |
Q3 2021 | $576,000 | -17.7% | 303,000 | +21.2% | 0.04% | +15.8% |
Q2 2021 | $700,000 | – | 250,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 1,010,000 | $1,919,000 | 1.00% |
Murchinson Ltd. | 320,947 | $610,000 | 0.30% |
SABBY MANAGEMENT, LLC | 425,014 | $808,000 | 0.11% |
Kepos Capital LP | 700,000 | $1,330,000 | 0.09% |
Antara Capital LP | 303,000 | $576,000 | 0.04% |
ZEKE CAPITAL ADVISORS, LLC | 93,800 | $178,000 | 0.01% |
Warberg Asset Management LLC | 26,000 | $49,000 | 0.01% |
Shay Capital LLC | 20,000 | $38,000 | 0.01% |
WELLS FARGO & COMPANY/MN | 122 | $0 | 0.00% |
NORTHERN TRUST CORP | 15,714 | $30,000 | 0.00% |